hotspot -WSS

hotspot

author：entertainment 2025-10-01 15:42:56 - browse：9

Adam's take main illustration — Molly Ferguson/STAT

Hello! Some takes and thoughts on Gilead’s Trodelvy troubles, Elevation Oncology’s surprising rise, and Kura Oncology’s “wall-crossing” stock sale.

Gilead needs Arcellx more than ever

The clinical trial setback for Trodelvy in non-small cell lung cancer reported by Gilead Sciences on Monday was another dose of bad news for the company’s oncology business. Strategically, does it make sense for Gilead to invest even more in antibody-drug conjugates like Trodelvy, where its lackluster profile and increased competition overall makes winning seem unlikely? Or, should Gilead double down on its Kite division and CAR-T cell therapy — the type of cancer treatments where it truly excels?

If the answers to those questions are no and yes (I lean that way), then Gilead’s current partnership with Arcellx, which is developing a BCMA-targeted CAR-T therapy for multiple myeloma, becomes a lot more important.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Zapping the brain for stroke rehab: Pivotal clinical trial begins

WSS

An Ebola outbreak presents a new mystery involving children

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

CDC launches VaccineFinder tool to locate Covid

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Wegovy’s successful heart trial raises vital question about weight loss

Maui's cultural, historic landmarks damaged in the devastating wildfires

explore

hotspot

Gilead needs Arcellx more than ever

leisure time

Sports medicine is finally prioritizing gender equality

Sage's campaign to raise awareness of postpartum depression hits a nerve

Tori Bowie and the unacceptable rates of Black maternal death

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

How to save PrEP access — and even expand it

Wegovy’s successful heart trial raises vital question about weight loss

Duchenne breakthrough therapy leaves behind pioneering families

Zapping the brain for stroke rehab: Pivotal clinical trial begins

Supreme Court strikes down use of affirmative action

Astronauts get first look at the spacecraft that will fly them around the moon

focus

NIH trials fail to test meaningful long Covid therapies, experts say

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Police still searching for prisoner who escaped from NYC hospital

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Wegovy cuts risk of cardiovascular events by 20%, study finds

Wikipedia

hotspot

leisure time

Wikipedia